China Universal Asset Management Co., Ltd. Ikena Oncology, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Oct 21, 2022	BUY	$3.46 - $6.0 $1,176 - $2,040	340 New	340 $1,000

Others Institutions Holding IKNA

# of Institutions

Shares Held

30.6M

Call Options Held

Put Options Held

Atlas Venture Life Science Advisors, LLC

5.02M
Shares

$7.88 Million
1.07% of portfolio
Bvf Inc San Francisco, CA

4.77M
Shares

$7.49 Million
0.26% of portfolio
Blue Owl Capital Holdings LP New York, NY

4.09M
Shares

$6.42 Million
2.33% of portfolio
Orbimed Advisors LLC San Diego, CA

3.54M
Shares

$5.56 Million
0.14% of portfolio
Omega Fund Management, LLC Boston, MA

2.25M
Shares

$3.53 Million
5.77% of portfolio

View Full List

About Ikena Oncology, Inc.

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $56.9M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

More about IKNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account